Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery
NCT00709436
Completed
The purpose of this research study is to evaluate the safety and analgesic efficacy of PMI-150 (intranasal ketamine) compared to placebo in patients with acute post-operative pain following orthopedic trauma, injury, or surgery.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
01/10/2012
Locations: Jefferson Clinic, Birmingham, Alabama +15 locations
Conditions: Pain, Postoperative
Register for Updates
Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients
NCT00492388
Terminated
To assess the safety and efficacy of PMI-150 (Intranasal Ketamine) as an analgesic for the treatment of breakthrough pain in cancer patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/10/2012
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Pain, Cancer
Register for Updates
Ketamine Frequency Treatment for Major Depressive Disorder
NCT00646087
Withdrawn
Depression is a wide spread illness. Depression contributes most significantly to national health care costs. While the number and types of treatments used for depression have expanded over the years, even with an increased range of options, the response rate, defined as the number of subjects who have a 50% reduction in depressive symptoms, is estimated to be around 65%. This randomized clinical trial will examine the frequency of treatment with ketamine in patients with treatment-resistant de... Read More
Gender:
ALL
Ages:
Between 30 years and 65 years
Trial Updated:
06/03/2011
Locations: St. Mary's Duluth Clinic Health System, Duluth, Minnesota
Conditions: Treatment Resistant Depression
Register for Updates
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
NCT00451724
Completed
The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.
Gender:
ALL
Ages:
Between 1 year and 7 years
Trial Updated:
07/21/2010
Locations: Hasbro Children's Hospital, Providence, Rhode Island
Conditions: Laceration
Register for Updates
Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
NCT00579085
Completed
Complex Regional Pain Syndrome is a debilitating and extremely difficult to treat condition. There is a large body of evidence demonstrating the therapeutic value of N-methyl-D-aspartate (NMDA)-receptor antagonists in CRPS. The NMDA antagonist ketamine has been shown to be effective in the treatment of CRPS, resulting in complete remission of the disease in some patients. The purpose of this study is to evaluate intravenous outpatient infusion of sub-anesthetic doses of ketamine for the treatmen... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
06/15/2010
Locations: Drexel University College of Medicine Department of Neurology, Philadelphia, Pennsylvania
Conditions: Complex Regional Pain Syndrome
Register for Updates
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
NCT00252122
Terminated
The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcotics).
Gender:
ALL
Ages:
Between 7 years and 18 years
Trial Updated:
03/12/2009
Locations: The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Conditions: Sickle Cell Disease
Register for Updates
Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)
NCT00662883
Completed
To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/21/2008
Locations: Not set, Baltimore, Maryland
Conditions: Healthy
Register for Updates
Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
NCT00520104
Unknown
This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/27/2008
Locations: Javelin Pharmaceuticals, Cambridge, Massachusetts
Conditions: Pharmacokinetics
Register for Updates
Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
NCT00520169
Completed
This is an open label, single-center study to determine the absolute bioavailability and nasopharyngeal absorption of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/09/2008
Locations: Javelin Pharmaceuticals, Cambridge, Massachusetts
Conditions: Healthy
Register for Updates
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
NCT00556361
Completed
To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.
Gender:
ALL
Ages:
1 year and below
Trial Updated:
11/09/2007
Locations: Arkansas Children's Hospital, Little Rock, Arkansas
Conditions: Ventricular Septal Defect
Register for Updates